Indian authorities have tightened norms on the sale of pain killer drug 'Diclofenac' following a directive by the National Human Rights Commission (NHRC), to prevent its misuse on animals, a petitioner said Wednesday.
In response to a petition filed by Odisha-based rights activist Akhand in May last year, the National Human rights Commission had sought a report from the union ministry of health and family welfare.
The ministry informed the commission that the government has made it mandatory that Diclofenac for human use shall be packed in single unit dose pack only, Akhand told IANS.
Diclofenac is used as painkiller for animals too.
"The government has prohibited the manufacture, sale and distribution of the drug and its formulation for animal use," Shailendra Kumar, Director (Drugs) in the Ministry of Health informed the commission in a letter a copy of which is in possession of IANS.
"In order to further restrict the illegal use of diclofenac injection in animals, the matter was considered by Drugs Technical Advisory Board (DTAB), a statutory body of the Central Government," Kumar stated in the letter.
The normal dose of the drug in animals is about 11 ml for three or four days while for humans it is only 3 ml per dose, the letter said.
Though painkiller drug Diclofenac has been banned for use on animals, it is readily available with the chemists and private drug stores across the country because it used to treat humans also, Akhand had in his petition to the NHRC.
Citing different reports, the activist had also blamed the misuse of drugs as one of the cause of decline in vulture population. "Mass killing of vultures creates environment imbalance that affect human life," he said.
"As carcasses, once eaten by vultures, now rot in village fields, drinking water has become seriously contaminated, endangering human life," he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
